KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only

The promising results of anaplastic lymphoma kinase (ALK) inhibitors have changed the significance of ALK fusions in several types of cancer. These fusions are no longer mere research targets or diagnostic markers, but they are now directly linked to the therapeutic benefit of patients. However, mos...

Descripción completa

Detalles Bibliográficos
Autores principales: Togashi, Yuki, Soda, Manabu, Sakata, Seiji, Sugawara, Emiko, Hatano, Satoko, Asaka, Reimi, Nakajima, Takashi, Mano, Hiroyuki, Takeuchi, Kengo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275577/
https://www.ncbi.nlm.nih.gov/pubmed/22347464
http://dx.doi.org/10.1371/journal.pone.0031323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275577/
https://www.ncbi.nlm.nih.gov/pubmed/22347464
http://dx.doi.org/10.1371/journal.pone.0031323

Ejemplares similares